VOA News reports on pilot program against lymphatic filariasis in Nigeria

NewsGuard 100/100 Score

VOA News reports on "a new public health strategy, tested in Nigeria," which is "raising hopes" that the tropical disease known as lymphatic filariasis (LF), or elephantiasis, can be eliminated. "The Nigeria Ministry of Health and the Carter Center, a philanthropic research institute established by former US. President Jimmy Carter, announced recently that they have successfully stopped the transmission of LF" in the test area near the northern Nigerian city of Jos, the news service notes. Adel Egege, director of the Carter Center's LF prevention program in Jos, described its mass drug administration initiative, "giving two anti-parasitic drugs to everyone in the region, and distributing mosquito-proof bed nets to most families to prevent the nighttime insect bites," the news service writes. "The results of the pilot program have been so promising, said Egege, that the Nigerian government is planning to expand the program throughout the entire country," VOA notes, adding, "Carter Center and Nigerian health officials are hopeful that, with a nationwide campaign, LF could be gone from Nigeria within six to 10 years, sparing future generations its terrible consequences" (Graitcer, 4/5).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research explores the health benefits of resistant starch in plant-based diets